{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:02:37Z","timestamp":1791828157175,"version":"4.3.4"},"reference-count":105,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2020,10,20]]},"abstract":"<jats:p>\n                    <jats:italic>Achromobacter<\/jats:italic>\n                    is a genus of nonfermenting Gram-negative bacteria under order\n                    <jats:italic>Burkholderiales<\/jats:italic>\n                    . Although primarily isolated from respiratory tract of people with cystic fibrosis,\n                    <jats:italic>Achromobacter<\/jats:italic>\n                    spp. can cause a broad range of infections in hosts with other underlying conditions. Their rare occurrence and ever-changing taxonomy hinder defining their clinical features, risk factors for acquisition and adverse outcomes, and optimal treatment.\n                    <jats:italic>Achromobacter<\/jats:italic>\n                    spp.\n                  <\/jats:p>","DOI":"10.1128\/aac.01025-20","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T09:41:42Z","timestamp":1597657302000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":184,"title":["<i>Achromobacter<\/i>\n                    Infections and Treatment Options"],"prefix":"10.1128","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1362-2434","authenticated-orcid":false,"given":"Burcu","family":"Isler","sequence":"first","affiliation":[{"name":"University of Queensland, Faculty of Medicine, UQ Center for Clinical Research, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Kidd","sequence":"additional","affiliation":[{"name":"Central Microbiology, Pathology Queensland, Royal Brisbane and Women\u2019s Hospital, Brisbane, Australia"},{"name":"University of Queensland, Faculty of Science, School of Chemistry and Molecular Biosciences, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7262-7529","authenticated-orcid":false,"given":"Adam G.","family":"Stewart","sequence":"additional","affiliation":[{"name":"University of Queensland, Faculty of Medicine, UQ Center for Clinical Research, Brisbane, Australia"},{"name":"Infectious Diseases Unit, Royal Brisbane and Women\u2019s Hospital, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Harris","sequence":"additional","affiliation":[{"name":"University of Queensland, Faculty of Medicine, UQ Center for Clinical Research, Brisbane, Australia"},{"name":"Central Microbiology, Pathology Queensland, Royal Brisbane and Women\u2019s Hospital, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Paterson","sequence":"additional","affiliation":[{"name":"University of Queensland, Faculty of Medicine, UQ Center for Clinical Research, Brisbane, Australia"},{"name":"Infectious Diseases Unit, Royal Brisbane and Women\u2019s Hospital, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","volume-title":"Bergey\u2019s manual of determinative bacteriology","author":"Bergey DH","year":"1923","unstructured":"Bergey DH, Harrison FC, Breed RS, Hammer BW, Huntoon FM. 1923. Bergey\u2019s manual of determinative bacteriology, vol 1. Williams & Wilkins, Baltimore, MD."},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1099\/ijsem.0.003786"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.1998.tb02306.x"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.syapm.2012.10.003"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1099\/ijs.0.02698-0"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1099\/ijsem.0.001254"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.syapm.2013.06.005"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00814-12"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2012.10.002"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268816002624"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ram.2019.03.004"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.000499"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2019.11.005"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2015.12.009"},{"key":"e_1_3_1_16_2","first-page":"1","volume-title":"Bergey\u2019s manual of systematics of Archaea and Bacteria","author":"Busse HJ","year":"2015","unstructured":"Busse HJ, Auling G. 2015. Achromobacter, p 1\u201314. In Bergey\u2019s manual of systematics of Archaea and Bacteria. Williams & Wilkins, Baltimore, MD."},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.11.3942-3945.2001"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2011.09.001"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00014-09"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00569-08"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01618-13"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.03.031"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2020.105889"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2011.07.004"},{"key":"e_1_3_1_25_2","volume-title":"Cefiderocol for the treatment of Achromobacter xylosoxidans infections in two lung transplant patients with cystic fibrosis","author":"Warner NC","year":"2019","unstructured":"Warner NC, Bartelt L, Lachiewicz A, Tompkins KM, Miller MB, van Duin D. 2019. Cefiderocol for the treatment of Achromobacter xylosoxidans infections in two lung transplant patients with cystic fibrosis, abstr 730. IDweek 2019, Washington, DC."},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000709"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4431-3"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.26.11.2425-2426.1988"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365540701558714"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2013.857043"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.03.031"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/icl.0000000000000587"},{"key":"e_1_3_1_33_2","first-page":"569","article-title":"Eradication of Achromobacter spp. multiresistente with colistin otic in patient with chronic otitis media suppurated","volume":"32","author":"Trujillano Ruiz A","year":"2019","unstructured":"Trujillano Ruiz A, Gimenez Castellanos J, Andreo Marroig JF, Mesquida Riera J, Cano Collado V. 2019. Eradication of Achromobacter spp. multiresistente with colistin otic in patient with chronic otitis media suppurated. Rev Esp Quimioter 32:569\u2013570. (In Spanish.)","journal-title":"Rev Esp Quimioter"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2018.05.003"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-012-0373-z"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-003-0925-3"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.8747"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04260-14"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/gbe\/evx061"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00341-11"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01243-12"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2015.11.013"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00290-17"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.1223"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01463-07"},{"key":"e_1_3_1_46_2","first-page":"621","article-title":"Hospital-acquired pneumonia due to Achromobacter spp. in a geriatric ward in China: clinical characteristic, genome variability, biofilm production, antibiotic resistance and integron in isolated strains","volume":"7","author":"Liu C","year":"2016","unstructured":"Liu C, Pan F, Guo J, Yan W, Jin Y, Liu C, Qin L, Fang X. 2016. Hospital-acquired pneumonia due to Achromobacter spp. in a geriatric ward in China: clinical characteristic, genome variability, biofilm production, antibiotic resistance and integron in isolated strains. Front Microbiol 7:621.","journal-title":"Front Microbiol"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-012-0213-5"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00224"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2014\/6877.3916"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1211.060143"},{"key":"e_1_3_1_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.41.12.5407-5413.2003"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.34.12.2909-2913.1996"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.4.1249-1253.2001"},{"key":"e_1_3_1_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00968-19"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-005-0054-2"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2005.06.018"},{"key":"e_1_3_1_57_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05640-11"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136790"},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26079-z"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12223-018-0639-7"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12896"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2018.08.014"},{"key":"e_1_3_1_63_2","volume-title":"CLSI reference for Table 2B-5 CLSI: methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria","author":"CLSI","year":"2016","unstructured":"CLSI. 2016. CLSI reference for Table 2B-5 CLSI: methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria, 3rd ed. Guideline M45. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"3"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2019.04.005"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2012.08.005"},{"key":"e_1_3_1_66_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01595-19"},{"key":"e_1_3_1_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.09.001"},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-016-0127-3"},{"key":"e_1_3_1_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2009.08.015"},{"key":"e_1_3_1_70_2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/978-1-4939-9034-4_26","volume-title":"Principles and practice of transplant infectious diseases","author":"Rolston KV","year":"2019","unstructured":"Rolston KV, Safdar A. 2019. Pseudomonas, Stenotrophomonas, Acinetobacter, and other nonfermentative Gram-negative bacteria and medically important anaerobic bacteria in transplant recipients, p 461\u2013472. In Principles and practice of transplant infectious diseases. Springer, New York, NY."},{"key":"e_1_3_1_71_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2011.0195"},{"key":"e_1_3_1_72_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00438-11"},{"key":"e_1_3_1_73_2","volume-title":"EUCAST Antimicrobial wild-type distributions of microorganisms","author":"EUCAST","year":"2020","unstructured":"EUCAST. 2020. EUCAST Antimicrobial wild-type distributions of microorganisms. EUCAST, Basel, Switzerland. https:\/\/mic.eucast.org\/Eucast2\/. Accession 19 May 2020."},{"key":"e_1_3_1_74_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201207-1160oe"},{"key":"e_1_3_1_75_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.2.912"},{"key":"e_1_3_1_76_2","doi-asserted-by":"publisher","DOI":"10.1097\/IM9.0000000000000014"},{"key":"e_1_3_1_77_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.6.1412"},{"key":"e_1_3_1_78_2","first-page":"268","article-title":"Achromobacter xylosoxidans bacteremia: clinical and microbiological features in a 10-year case series","volume":"31","author":"Perez Barragan E","year":"2018","unstructured":"Perez Barragan E, Sandino Perez J, Corbella L, Orellana MA, Fernandez-Ruiz M. 2018. Achromobacter xylosoxidans bacteremia: clinical and microbiological features in a 10-year case series. Rev Esp Quimioter 31:268\u2013273.","journal-title":"Rev Esp Quimioter"},{"key":"e_1_3_1_79_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201701-071OC"},{"key":"e_1_3_1_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2013.04.013"},{"key":"e_1_3_1_81_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.2.479"},{"key":"e_1_3_1_82_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcs048"},{"key":"e_1_3_1_83_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01713580"},{"key":"e_1_3_1_84_2","doi-asserted-by":"crossref","unstructured":"Burnard D Robertson G Henderson A Falconer C Bauer-Leo M Cottrell K Gassiep I Norton R Paterson DL Harris PNA. 2020. Burkholderia pseudomallei clinical isolates are highly susceptible in vitro to cefiderocol a novel siderophore cephalosporin. bioRxiv doi:10.1101\/2020.03.26.009134:2020.03.26.009134.","DOI":"10.1101\/2020.03.26.009134"},{"key":"e_1_3_1_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.11.007"},{"key":"e_1_3_1_86_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy210.1206"},{"key":"e_1_3_1_87_2","volume-title":"Cefiderocol briefing document","author":"FDA Antimicrobial Drugs Advisory Committee","year":"2019","unstructured":"FDA Antimicrobial Drugs Advisory Committee. 2019. Cefiderocol briefing document. NDA 2094445. Shionogi, Inc, Florham Park, NJ."},{"key":"e_1_3_1_88_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz360.1953"},{"key":"e_1_3_1_89_2","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12955"},{"key":"e_1_3_1_90_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.000801"},{"key":"e_1_3_1_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2018.03.002"},{"key":"e_1_3_1_92_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy158"},{"key":"e_1_3_1_93_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02688-16"},{"key":"e_1_3_1_94_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00572-10"},{"key":"e_1_3_1_95_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00117-14"},{"key":"e_1_3_1_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.resmic.2018.05.001"},{"key":"e_1_3_1_97_2","doi-asserted-by":"publisher","DOI":"10.1556\/650.2018.30926"},{"key":"e_1_3_1_98_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268816001564"},{"key":"e_1_3_1_99_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.02293-13"},{"key":"e_1_3_1_100_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-011-1182-5"},{"key":"e_1_3_1_101_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2008.00995.x"},{"key":"e_1_3_1_102_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-6-4"},{"key":"e_1_3_1_103_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20604"},{"key":"e_1_3_1_104_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762005000600011"},{"key":"e_1_3_1_105_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/26.6.857"},{"key":"e_1_3_1_106_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.32.2.276"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01025-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01025-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T16:37:16Z","timestamp":1645461436000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01025-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,20]]},"references-count":105,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,10,20]]}},"alternative-id":["10.1128\/AAC.01025-20"],"URL":"https:\/\/doi.org\/10.1128\/aac.01025-20","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,20]]},"assertion":[{"value":"2020-10-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01025-20"}}